Skip to main content

Table 2 Clinical outcome for bona fide GCT and GTN patients who received Em-EP. Median follow-up time, 9 months

From: Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)

Clinical outcome GCT patients, n = 50 (%) GTN patients, n = 45 (%)
Alive at 4 weeks 49 (98%) 44 (98%)
Alive at 6 months 46 (92%) 44 (98%)
Resistant disease (first relapse) 19 (38%) 8 (18%)
Alive at follow-up 36 (72%) 44 (98%)
Deaths at follow-up 14 (28%) 1 (2%)
Causes of death • Disease progression (n = 8, 57%)
• Sepsis (n = 2, 14%)
• Unknown (n = 4, 29%)
• Disease progression (n = 1, 100%)